In the extremely regulated biotechnology market, all business decisions, including the selection of a suitable environmental monitoring system, must be made with due regard to the applicable GMP guidelines. Under these conditions, an innovative start-up company wants to enter the biotechnology market with superior, cost-efficient allografts and regenerative clinical solutions. Next to a user-friendly environmental monitoring system, they are also looking for an experienced partner who can support them in setting up GxP-compliant production and logistics.
In this case study, you will learn how a regenerative medicine start-up company:
we prove it.
Copyright © ELPRO-BUCHS AG 2023. All Rights Reserved.